Vericel
Stephanie Osborn is a Principal Scientist at Vericel® Corporation and a Senior Scientist at UC Davis Health. With a background in Molecular and Cell Biology/Immunology, Osborn has extensive experience in developing bioengineered tissue for bladder transplants, cell therapy for bladder cancer, and precision medicine targeting cancer stem cells. Osborn has also contributed to research on immune responses, necroptosis, and signaling pathways related to T cells.
Vericel
Vericel (NASDAQ:VCEL) develops, manufactures and markets autologous expanded cell therapies for the treatment of patients with serious diseases and conditions